News
1hon MSN
India's Dr Reddy's plans to launch generic obesity drugs in 87 countries next year, CEO says
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...
Syngene International's profit after tax surged 59% to Rs 87 crore in Q1 2025, driven by revenue growth and a tax benefit.
With over three decades of experience across India, ASEAN, and Australia, Deepali Naair brings deep expertise in brand ...
Biocon Biologics appoints Deepali Naair as Global Head of Brand & Corporate Communications. She brings 30+ years experience ...
On Wednesday, 2005 stocks advanced, 2025 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...
Explore more
Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...
This article highlights the top B.Tech Biotechnology colleges in India for 2025, detailing their course durations, fees, and ...
Syngene's margins narrowed on a sequential basis. Apart from margins, Syngene's revenue and EBITDA are also lower by 14.1% ...
Naair succeeds Seema Ahuja as the later moves into a non-business-facing role. Naair is expected to lead the global brand and ...
Deepali joins from CKA Birla Group, where she was working as group chief marketing officer will now report directly to Shreehas Tambe, CEO & managing director, Biocon Biologics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results